Transcode Therapeutics, Inc. Contracts & Agreements
37 Contracts & Agreements
- Business Finance (25 contracts)
- Business Operations (2)
- Human Resources (4)
- Intellectual Property (2)
- Uncategorized (4)
- Form of Underwriting Agreement (Filed With SEC on September 25, 2023)
- Form of Pre-funded Warrant (Filed With SEC on September 11, 2023)
- Form of Underwriting Agreement (Filed With SEC on September 11, 2023)
- Certificate of Amendment to Amended and Restated Certificate of Incorporation of TransCode Therapeutics, Inc (Filed With SEC on August 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 8, 2023)
- Form of Common stock purchase warrant (Filed With SEC on June 6, 2023)
- Form of Pre-funded Warrant (Filed With SEC on June 6, 2023)
- Form of Placement Agent Warrant (Filed With SEC on June 6, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 6, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 5, 2023)
- Form of Placement Agent Warrant (Filed With SEC on June 5, 2023)
- Form of Pre-funded Warrant (Filed With SEC on June 5, 2023)
- Form of Common stock purchase warrant (Filed With SEC on June 5, 2023)
- Common Stock Purchase Agreement, dated April 13, 2023, by and between TransCode Therapeutics,Inc. and White Lion Capital LLC (Filed With SEC on April 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 17, 2023)
- Form of Placement Agent Warrant (Filed With SEC on February 17, 2023)
- Form of Pre-funded Warrant (Filed With SEC on February 1, 2023)
- Form of Underwriting Agreement (Filed With SEC on February 1, 2023)
- Form of Pre-funded Warrant (Filed With SEC on November 28, 2022)
- Form of Representative Warrant (Filed With SEC on November 28, 2022)
- Form of Underwriting Agreement (Filed With SEC on November 28, 2022)
- Description of Securities (Filed With SEC on March 31, 2022)
- Form of Underwriting Agreement (Filed With SEC on April 8, 2021)
- Specimen Common Stock Certificate (Filed With SEC on April 8, 2021)
- Employment Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Robert Michael Dudley (Filed With SEC on April 8, 2021)
- Letter Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Robert Michael Dudley (Filed With SEC on April 8, 2021)
- Employment Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Thomas A. Fitzgerald (Filed With SEC on April 8, 2021)
- Letter Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Thomas A. Fitzgerald (Filed With SEC on April 8, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on March 24, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors (Filed With SEC on March 24, 2021)
- Form of Indemnification Agreement between the Registrant and each of its executive officers (Filed With SEC on March 24, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on March 24, 2021)
- 2021 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on March 24, 2021)
- Form of Representative Warrant (Filed With SEC on March 24, 2021)
- 2020 Stock Option and Grant Plan and form of award agreements thereunder (Filed With SEC on February 26, 2021)
- First Amendment to Exclusive Patent License Agreement by and between TransCode Therapeutics, Inc. and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated... (Filed With SEC on February 26, 2021)
- Exclusive Patent License Agreement by and between TransCode Therapeutics, Inc. and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated as of October 26,... (Filed With SEC on February 26, 2021)
